0|chunk|HIV Antigen Incorporation within Adenovirus Hexon Hypervariable 2 for a Novel HIV Vaccine Approach
0	4	11 Antigen	Chemical	CHEBI_59132
0	44	49 Hexon	Chemical	CHEBI_82344
0	CHEBI-CHEBI	CHEBI_59132	CHEBI_82344

1|chunk|Traditionally, Ad-based vaccines are designed to express antigens through transgene expression of a given antigen. However, in some cases these conventional Ad-based vaccines have had sub-optimal clinical results. These sub-optimal results are attributed in part to pre-existing Ad serotype 5 (Ad5) immunity. In order to circumvent the need for antigen expression via transgene incorporation, the ''antigen capsid-incorporation'' strategy has been developed and used for Adbased vaccine development in the context of a few diseases. This strategy embodies the incorporation of antigenic peptides within the capsid structure of viral vectors. The major capsid protein hexon has been utilized for these capsid incorporation strategies due to hexon's natural role in the generation of anti-Ad immune response and its numerical representation within the Ad virion. Using this strategy, we have developed the means to incorporate heterologous peptide epitopes specifically within the major surface-exposed domains of the Ad capsid protein hexon. Our study herein focuses on generation of multivalent vaccine vectors presenting HIV antigens within the Ad capsid protein hexon, as well as expressing an HIV antigen as a transgene. These novel vectors utilize HVR2 as an incorporation site for a twenty-four amino acid region of the HIV membrane proximal ectodomain region (MPER), derived from HIV glycoprotein gp41 (gp41). Our study herein illustrates that our multivalent anti-HIV vectors elicit a cellular anti-HIV response. Furthermore, vaccinations with these vectors, which present HIV antigens at HVR2, elicit a HIV epitope-specific humoral immune response.
1	57	65 antigens	Chemical	CHEBI_59132
1	106	113 antigen	Chemical	CHEBI_59132
1	345	352 antigen	Chemical	CHEBI_59132
1	587	595 peptides	Chemical	CHEBI_16670
1	659	666 protein	Chemical	CHEBI_16541
1	667	672 hexon	Chemical	CHEBI_82344
1	740	745 hexon	Chemical	CHEBI_82344
1	756	760 role	Chemical	CHEBI_50906
1	938	945 peptide	Chemical	CHEBI_16670
1	1026	1033 protein	Chemical	CHEBI_16541
1	1034	1039 hexon	Chemical	CHEBI_82344
1	1126	1134 antigens	Chemical	CHEBI_59132
1	1156	1163 protein	Chemical	CHEBI_16541
1	1164	1169 hexon	Chemical	CHEBI_82344
1	1200	1207 antigen	Chemical	CHEBI_59132
1	1300	1305 amino	Chemical	CHEBI_46882
1	1300	1310 amino acid	Chemical	CHEBI_33704
1	1306	1310 acid	Chemical	CHEBI_37527
1	1390	1402 glycoprotein	Chemical	CHEBI_17089
1	1584	1592 antigens	Chemical	CHEBI_59132
1	CHEBI-CHEBI	CHEBI_59132	CHEBI_16670
1	CHEBI-CHEBI	CHEBI_59132	CHEBI_16541
1	CHEBI-CHEBI	CHEBI_59132	CHEBI_82344
1	CHEBI-CHEBI	CHEBI_59132	CHEBI_50906
1	CHEBI-CHEBI	CHEBI_59132	CHEBI_46882
1	CHEBI-CHEBI	CHEBI_59132	CHEBI_33704
1	CHEBI-CHEBI	CHEBI_59132	CHEBI_37527
1	CHEBI-CHEBI	CHEBI_59132	CHEBI_17089
1	CHEBI-CHEBI	CHEBI_16670	CHEBI_16541
1	CHEBI-CHEBI	CHEBI_16670	CHEBI_82344
1	CHEBI-CHEBI	CHEBI_16670	CHEBI_50906
1	CHEBI-CHEBI	CHEBI_16670	CHEBI_46882
1	CHEBI-CHEBI	CHEBI_16670	CHEBI_33704
1	CHEBI-CHEBI	CHEBI_16670	CHEBI_37527
1	CHEBI-CHEBI	CHEBI_16670	CHEBI_17089
1	CHEBI-CHEBI	CHEBI_16541	CHEBI_82344
1	CHEBI-CHEBI	CHEBI_16541	CHEBI_50906
1	CHEBI-CHEBI	CHEBI_16541	CHEBI_46882
1	CHEBI-CHEBI	CHEBI_16541	CHEBI_33704
1	CHEBI-CHEBI	CHEBI_16541	CHEBI_37527
1	CHEBI-CHEBI	CHEBI_16541	CHEBI_17089
1	CHEBI-CHEBI	CHEBI_82344	CHEBI_50906
1	CHEBI-CHEBI	CHEBI_82344	CHEBI_46882
1	CHEBI-CHEBI	CHEBI_82344	CHEBI_33704
1	CHEBI-CHEBI	CHEBI_82344	CHEBI_37527
1	CHEBI-CHEBI	CHEBI_82344	CHEBI_17089
1	CHEBI-CHEBI	CHEBI_50906	CHEBI_46882
1	CHEBI-CHEBI	CHEBI_50906	CHEBI_33704
1	CHEBI-CHEBI	CHEBI_50906	CHEBI_37527
1	CHEBI-CHEBI	CHEBI_50906	CHEBI_17089
1	CHEBI-CHEBI	CHEBI_46882	CHEBI_33704
1	CHEBI-CHEBI	CHEBI_46882	CHEBI_37527
1	CHEBI-CHEBI	CHEBI_46882	CHEBI_17089
1	CHEBI-CHEBI	CHEBI_33704	CHEBI_37527
1	CHEBI-CHEBI	CHEBI_33704	CHEBI_17089
1	CHEBI-CHEBI	CHEBI_37527	CHEBI_17089

